ArticleClinical and molecular hepatology2026

Clarifying residual drug effects and subgroup outcomes in TDF-to-BSV switch trials: Letter to the editor on "Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial".

Lihuang Su et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.